JCO-话题@MedSci

#JCO#

724篇内容 | 6931人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1891595, encodeId=e13018915958d, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：东方肝胆外科医院程树群教授团队发文：三维适形新辅助放疗显著改善可切除HCC伴PVTT患者的OS, objectType=article, longId=175184, objectId=78551e518428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78551e518428, replyNumber=0, likeNumber=76, createdTime=2019-10-25, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78551e518428, moduleTitle=JCO：东方肝胆外科医院程树群教授团队发文：三维适形新辅助放疗显著改善可切除HCC伴PVTT患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78551e518428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891594, encodeId=d5c01891594f2, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO Precis Oncol：原发性和转移性前列腺肿瘤的前瞻性综合基因组分析, objectType=article, longId=174936, objectId=c2c11e49360a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2c11e49360a, replyNumber=0, likeNumber=128, createdTime=2020-06-04, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2c11e49360a, moduleTitle=JCO Precis Oncol：原发性和转移性前列腺肿瘤的前瞻性综合基因组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2c11e49360a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891588, encodeId=07651891588fa, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果, objectType=article, longId=165945, objectId=10d1165945f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10d1165945f6, replyNumber=0, likeNumber=64, createdTime=2019-11-20, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10d1165945f6, moduleTitle=JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10d1165945f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891578, encodeId=360618915e80d, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：多发性骨髓瘤的自体移植，巩固和维持治疗, objectType=article, longId=158472, objectId=026b1584e2f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=026b1584e2f4, replyNumber=0, likeNumber=93, createdTime=2019-02-17, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=026b1584e2f4, moduleTitle=JCO：多发性骨髓瘤的自体移植，巩固和维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=026b1584e2f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891598, encodeId=00961891598f2, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, objectType=article, longId=177361, objectId=414c1e7361c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=414c1e7361c0, replyNumber=0, likeNumber=67, createdTime=2020-06-03, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=414c1e7361c0, moduleTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=414c1e7361c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891581, encodeId=06731891581c1, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：氟嘧啶、伊立替康和贝伐珠单抗序贯治疗vs初始三药联合用于转移性结直肠癌孰优孰劣？, objectType=article, longId=159714, objectId=8fb6159e1401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fb6159e1401, replyNumber=0, likeNumber=86, createdTime=2019-03-04, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fb6159e1401, moduleTitle=JCO：氟嘧啶、伊立替康和贝伐珠单抗序贯治疗vs初始三药联合用于转移性结直肠癌孰优孰劣？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fb6159e1401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891604, encodeId=1cf4189160484, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：流感疫苗在癌症患者中的有效性, objectType=article, longId=178484, objectId=98d71e8484e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98d71e8484e8, replyNumber=0, likeNumber=77, createdTime=2020-08-04, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98d71e8484e8, moduleTitle=JCO：流感疫苗在癌症患者中的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98d71e8484e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891570, encodeId=231618915e028, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：EGFR突变腺癌转化为非小细胞肺癌和其他神经内分泌肿瘤, objectType=article, longId=156262, objectId=1e611562623b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e611562623b, replyNumber=0, likeNumber=59, createdTime=2019-09-09, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e611562623b, moduleTitle=JCO：EGFR突变腺癌转化为非小细胞肺癌和其他神经内分泌肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e611562623b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891602, encodeId=8d161891602cd, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：HER2阳性转移性乳腺癌研究进展, objectType=article, longId=178332, objectId=005e1e833230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005e1e833230, replyNumber=0, likeNumber=66, createdTime=2019-09-21, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005e1e833230, moduleTitle=JCO：HER2阳性转移性乳腺癌研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005e1e833230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891589, encodeId=b5e41891589d2, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：利用无血浆细胞DNA进行膀胱癌的早期检测, objectType=article, longId=165947, objectId=197316594e58, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=197316594e58, replyNumber=0, likeNumber=83, createdTime=2020-04-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=197316594e58, moduleTitle=JCO：利用无血浆细胞DNA进行膀胱癌的早期检测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=197316594e58)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891593, encodeId=b554189159351, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：GOG-0218最终OS结果出炉：贝伐珠单抗一线维持治疗卵巢癌未能改善生存, objectType=article, longId=174675, objectId=e49b1e46756a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e49b1e46756a, replyNumber=0, likeNumber=90, createdTime=2020-06-09, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e49b1e46756a, moduleTitle=JCO：GOG-0218最终OS结果出炉：贝伐珠单抗一线维持治疗卵巢癌未能改善生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e49b1e46756a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891580, encodeId=205a18915806a, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：tamoxifen的药物遗传学与代谢, objectType=article, longId=159075, objectId=7bd41590e5f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bd41590e5f2, replyNumber=0, likeNumber=102, createdTime=2019-01-29, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bd41590e5f2, moduleTitle=JCO：tamoxifen的药物遗传学与代谢, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bd41590e5f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891586, encodeId=e59518915868c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：低剂量他莫昔芬预防乳腺上皮内瘤变复发：随机安慰剂对照试验, objectType=article, longId=164160, objectId=ccfe16416038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccfe16416038, replyNumber=0, likeNumber=58, createdTime=2020-03-10, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccfe16416038, moduleTitle=JCO：低剂量他莫昔芬预防乳腺上皮内瘤变复发：随机安慰剂对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccfe16416038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891607, encodeId=c702189160e84, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：乳腺癌患者中的脂肪组织分布和心血管疾病风险的相关性, objectType=article, longId=180946, objectId=c45c1809462f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c45c1809462f, replyNumber=0, likeNumber=59, createdTime=2020-01-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c45c1809462f, moduleTitle=JCO：乳腺癌患者中的脂肪组织分布和心血管疾病风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c45c1809462f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891564, encodeId=6926189156422, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：利妥昔单抗时代滤泡性淋巴瘤死亡原因：队列汇总分析, objectType=article, longId=154619, objectId=34e2154619e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e2154619e9, replyNumber=0, likeNumber=0, createdTime=2019-11-09, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e2154619e9, moduleTitle=JCO：利妥昔单抗时代滤泡性淋巴瘤死亡原因：队列汇总分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34e2154619e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891563, encodeId=172218915633b, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效, objectType=article, longId=154370, objectId=61761543e050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61761543e050, replyNumber=0, likeNumber=80, createdTime=2019-11-01, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61761543e050, moduleTitle=JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61761543e050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891603, encodeId=48fb1891603d0, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：肝细胞癌治疗进展, objectType=article, longId=178334, objectId=84aa1e8334aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84aa1e8334aa, replyNumber=0, likeNumber=83, createdTime=2020-08-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84aa1e8334aa, moduleTitle=JCO：肝细胞癌治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84aa1e8334aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891577, encodeId=e3d818915e770, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验, objectType=article, longId=158471, objectId=e6371584e194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6371584e194, replyNumber=0, likeNumber=82, createdTime=2019-09-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6371584e194, moduleTitle=JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6371584e194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891566, encodeId=70e3189156613, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后, objectType=article, longId=154705, objectId=7bee154e0525, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bee154e0525, replyNumber=0, likeNumber=72, createdTime=2019-06-24, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bee154e0525, moduleTitle=JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bee154e0525)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891562, encodeId=0d6f189156276, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布, objectType=article, longId=154054, objectId=68de15405428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68de15405428, replyNumber=0, likeNumber=77, createdTime=2019-02-26, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68de15405428, moduleTitle=JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68de15405428)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JCO

2020-05-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：东方肝胆外科医院程树群教授团队发文：三维适形新辅助放疗显著改善可切除HCC伴PVTT患者的OS

2019-10-25

智智灵药 (审核中...)

前往app查看评论内容

#JCO#

JCO Precis Oncol：原发性和转移性前列腺肿瘤的前瞻性综合基因组分析

2020-06-04

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：局部巩固疗法与维持治疗或观察对低变应性非小细胞肺癌患者的效果

2019-11-20

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：多发性骨髓瘤的自体移植，巩固和维持治疗

2019-02-17

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究

2020-06-03

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：氟嘧啶、伊立替康和贝伐珠单抗序贯治疗vs初始三药联合用于转移性结直肠癌孰优孰劣？

2019-03-04

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：流感疫苗在癌症患者中的有效性

2020-08-04

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：EGFR突变腺癌转化为非小细胞肺癌和其他神经内分泌肿瘤

2019-09-09

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：HER2阳性转移性乳腺癌研究进展

2019-09-21

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：利用无血浆细胞DNA进行膀胱癌的早期检测

2020-04-05

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：GOG-0218最终OS结果出炉：贝伐珠单抗一线维持治疗卵巢癌未能改善生存

2020-06-09

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：tamoxifen的药物遗传学与代谢

2019-01-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：低剂量他莫昔芬预防乳腺上皮内瘤变复发：随机安慰剂对照试验

2020-03-10

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：乳腺癌患者中的脂肪组织分布和心血管疾病风险的相关性

2020-01-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：利妥昔单抗时代滤泡性淋巴瘤死亡原因：队列汇总分析

2019-11-09

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效

2019-11-01

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：肝细胞癌治疗进展

2020-08-05

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：卡铂和紫杉醇对未知原发癌患者的部位特异性治疗：II期临床试验

2019-09-05

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：EGFR突变非小细胞肺癌患者接受厄洛替尼辅助治疗可以改善预后

2019-06-24

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：洛莫司汀联合化疗改善老年AML患者的生存？LAM-SA 2007全新结果公布

2019-02-26

科室
- - 订阅+
  - 更多科室
工具
服务